Trademark: 97092394
Word
TEDOPI
Status Date
Monday, April 29, 2024
Filing Date
Tuesday, October 26, 2021
Published for Opposition
Tuesday, September 6, 2022
5 Pharmaceutical products for cancer treatment, oncology and immunotherapy; Sanitary preparations for medical use; Pharmaceutical products for use in human medicine for cancer treatment, oncology and immunotherapy; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer treatment, oncology and immunotherapy; Vaccines; Medicated serums for cancer treatment, oncology and immunotherapy; Chemical reagents for medical purposes
The wording TEDOPI has no meaning in a foreign language.
Oct 29, 2021
New Application Entered
Nov 9, 2021
New Application Office Supplied Data Entered
Aug 3, 2022
Assigned To Examiner
Aug 3, 2022
Approved For Pub - Principal Register
Aug 17, 2022
Notification Of Notice Of Publication E-Mailed
Sep 6, 2022
Published For Opposition
Sep 6, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 1, 2022
Noa E-Mailed - Sou Required From Applicant
Apr 28, 2023
Sou Teas Extension Received
Apr 28, 2023
Sou Extension 1 Filed
Apr 28, 2023
Sou Extension 1 Granted
May 2, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 26, 2023
Sou Teas Extension Received
Oct 26, 2023
Sou Extension 2 Filed
Oct 26, 2023
Sou Extension 2 Granted
Oct 28, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 29, 2024
Sou Teas Extension Received
Apr 29, 2024
Sou Extension 3 Granted
Apr 29, 2024
Sou Extension 3 Filed
Apr 30, 2024
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
